EGX OKs listing Rameda’s capital increase

This increase is distributed over 12.935 million shares at a nominal value of EGP 0.25 per share

Staff Writer, Arab Finance

July 10, 2024

PHOTO

The Egyptian Exchange’s (EGX) listing committee has approved listing an increase of EGP 3.234 million for Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) issued and paid-up capital, the EGX announced on July 10th.

This increase is distributed over 12.935 million shares at a nominal value of EGP 0.25 per share.

Accordingly, the capital will be raised to EGP 378.234 million from EGP 375 million.

The company's capital after the increase will be listed on the EGX's database on July 15th.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.